S&P 500   2,666.82 (+0.12%)
DOW   22,733.36 (+0.24%)
QQQ   196.53 (+0.03%)
AAPL   260.09 (-0.91%)
FB   169.41 (+2.33%)
MSFT   163.55 (-1.04%)
GOOGL   1,184.75 (+0.13%)
AMZN   2,009.66 (+0.60%)
NVDA   258.79 (-3.58%)
BABA   198.81 (+1.20%)
MU   46.91 (+1.16%)
TSLA   546.11 (+5.79%)
AMD   47.83 (+0.63%)
T   30.30 (+2.92%)
ACB   0.81 (+0.00%)
NFLX   373.43 (-1.72%)
BAC   22.27 (+4.11%)
S&P 500   2,666.82 (+0.12%)
DOW   22,733.36 (+0.24%)
QQQ   196.53 (+0.03%)
AAPL   260.09 (-0.91%)
FB   169.41 (+2.33%)
MSFT   163.55 (-1.04%)
GOOGL   1,184.75 (+0.13%)
AMZN   2,009.66 (+0.60%)
NVDA   258.79 (-3.58%)
BABA   198.81 (+1.20%)
MU   46.91 (+1.16%)
TSLA   546.11 (+5.79%)
AMD   47.83 (+0.63%)
T   30.30 (+2.92%)
ACB   0.81 (+0.00%)
NFLX   373.43 (-1.72%)
BAC   22.27 (+4.11%)
S&P 500   2,666.82 (+0.12%)
DOW   22,733.36 (+0.24%)
QQQ   196.53 (+0.03%)
AAPL   260.09 (-0.91%)
FB   169.41 (+2.33%)
MSFT   163.55 (-1.04%)
GOOGL   1,184.75 (+0.13%)
AMZN   2,009.66 (+0.60%)
NVDA   258.79 (-3.58%)
BABA   198.81 (+1.20%)
MU   46.91 (+1.16%)
TSLA   546.11 (+5.79%)
AMD   47.83 (+0.63%)
T   30.30 (+2.92%)
ACB   0.81 (+0.00%)
NFLX   373.43 (-1.72%)
BAC   22.27 (+4.11%)
S&P 500   2,666.82 (+0.12%)
DOW   22,733.36 (+0.24%)
QQQ   196.53 (+0.03%)
AAPL   260.09 (-0.91%)
FB   169.41 (+2.33%)
MSFT   163.55 (-1.04%)
GOOGL   1,184.75 (+0.13%)
AMZN   2,009.66 (+0.60%)
NVDA   258.79 (-3.58%)
BABA   198.81 (+1.20%)
MU   46.91 (+1.16%)
TSLA   546.11 (+5.79%)
AMD   47.83 (+0.63%)
T   30.30 (+2.92%)
ACB   0.81 (+0.00%)
NFLX   373.43 (-1.72%)
BAC   22.27 (+4.11%)
Log in

NASDAQ:PGNXProgenics Pharmaceuticals SEC Filings & 10K Form

$3.01
-0.22 (-6.81 %)
(As of 04/7/2020 04:00 PM ET)
Add
Compare
Today's Range
$2.99
Now: $3.01
$3.48
50-Day Range
$2.11
MA: $3.88
$5.16
52-Week Range
$1.89
Now: $3.01
$6.37
Volume699,378 shs
Average Volume1.24 million shs
Market Capitalization$260.67 million
P/E RatioN/A
Dividend YieldN/A
Beta2.16

SEC Filings

Progenics Pharmaceuticals (NASDAQ:PGNX) SEC Filings

DateFilerForm TypeView
04/02/2020
8:02 AM
Progenics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/02/2020
8:00 AM
Progenics Pharmaceuticals (Subject)
Form 425
04/02/2020
7:34 AM
Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form 425
04/01/2020
3:44 PM
Progenics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/19/2020
8:05 AM
Progenics Pharmaceuticals (Filer)
Form DEFM14A
03/16/2020
5:03 AM
Progenics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/13/2020
7:45 AM
Progenics Pharmaceuticals (Subject)
Form 425
03/13/2020
7:45 AM
Progenics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2020
3:15 PM
Das Asha (Reporting)
Progenics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2020
3:15 PM
Osorio Benedict (Reporting)
Progenics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2020
3:15 PM
Progenics Pharmaceuticals (Issuer)
Wong Vivien (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2020
3:15 PM
Progenics Pharmaceuticals (Issuer)
Tenbarge Bryce (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/04/2020
3:15 PM
Fabbio Patrick (Reporting)
Progenics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2020
3:20 PM
Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form 425
02/20/2020
4:18 PM
Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form 425
02/20/2020
3:59 PM
Progenics Pharmaceuticals (Subject)
Form 425
02/20/2020
12:27 PM
Progenics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/20/2020
12:25 PM
Progenics Pharmaceuticals (Subject)
Form 425
02/20/2020
11:25 AM
Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form 425
02/14/2020
10:25 AM
ARMISTICE CAPITAL, LLC (Filed by)
Progenics Pharmaceuticals (Subject)
Form SC 13G/A
02/14/2020
5:19 AM
FARALLON CAPITAL MANAGEMENT LLC (Filed by)
Progenics Pharmaceuticals (Subject)
Form SC 13G/A
02/13/2020
11:11 AM
Progenics Pharmaceuticals (Subject)
STATE STREET CORP (Filed by)
Form SC 13G
02/04/2020
11:30 AM
BlackRock Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form SC 13G/A
01/21/2020
4:27 PM
Progenics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2020
3:33 PM
Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form 425
01/08/2020
4:19 PM
Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form 425
01/06/2020
11:23 AM
EAGLE ASSET MANAGEMENT INC (Filed by)
Progenics Pharmaceuticals (Subject)
Form SC 13G/A
12/23/2019
6:32 AM
Progenics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/19/2019
3:03 PM
Progenics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/17/2019
2:16 PM
Maeusli Heinz Christoph (Reporting)
Progenics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
2:16 PM
Maeusli Heinz Christoph (Reporting)
Progenics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
2:16 PM
Mims David W. (Reporting)
Progenics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
2:15 PM
Mims David W. (Reporting)
Progenics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
2:15 PM
MacDougall Ann L. (Reporting)
Progenics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
2:15 PM
MacDougall Ann L. (Reporting)
Progenics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
2:14 PM
Ende Eric J (Reporting)
Progenics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
2:14 PM
Ende Eric J (Reporting)
Progenics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
2:14 PM
Ber Gerard (Reporting)
Progenics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
2:14 PM
Ber Gerard (Reporting)
Progenics Pharmaceuticals (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/21/2019
3:12 PM
Progenics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/15/2019
3:51 PM
Progenics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/12/2019
12:47 PM
Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form SC 13D/A
11/12/2019
5:07 AM
Progenics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/08/2019
4:21 PM
Progenics Pharmaceuticals (Filer)
Form DEFA14A
11/08/2019
2:52 PM
Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form DFAN14A
11/07/2019
4:05 PM
Progenics Pharmaceuticals (Subject)
Form 425
11/07/2019
9:08 AM
Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form 425
11/07/2019
7:31 AM
Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form 425
11/07/2019
7:15 AM
Progenics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/06/2019
4:07 PM
Progenics Pharmaceuticals (Filer)
Form DEFA14A
11/06/2019
4:07 PM
Progenics Pharmaceuticals (Subject)
Form 425
11/05/2019
3:45 PM
Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form DFAN14A
11/05/2019
8:15 AM
Progenics Pharmaceuticals (Filer)
Form DEFA14A
11/05/2019
8:12 AM
Progenics Pharmaceuticals (Subject)
Form 425
11/04/2019
10:10 AM
Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form DFAN14A
11/01/2019
4:11 PM
Progenics Pharmaceuticals (Subject)
Form 425
11/01/2019
4:09 PM
Progenics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/01/2019
4:07 PM
Progenics Pharmaceuticals (Subject)
Form 425
11/01/2019
8:03 AM
Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form 425
10/28/2019
4:10 PM
Progenics Pharmaceuticals (Subject)
Form 425
10/28/2019
9:49 AM
Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form DFAN14A
10/24/2019
2:03 PM
Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form DFAN14A
10/23/2019
4:12 PM
Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form DFAN14A
10/23/2019
3:29 PM
Progenics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/23/2019
3:28 PM
Progenics Pharmaceuticals (Subject)
Form 425
10/23/2019
3:22 PM
Progenics Pharmaceuticals (Subject)
Form 425
10/23/2019
8:01 AM
Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form 425
10/22/2019
10:32 AM
Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form DFAN14A
10/21/2019
6:32 PM
Progenics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/21/2019
6:30 PM
Progenics Pharmaceuticals (Subject)
Form 425
10/21/2019
4:05 PM
Progenics Pharmaceuticals (Subject)
Form 425
10/21/2019
11:06 AM
Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form DFAN14A
10/18/2019
4:04 PM
Progenics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/16/2019
11:46 AM
Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form DFAN14A
10/11/2019
3:03 PM
Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form DFRN14A
10/09/2019
7:27 PM
Progenics Pharmaceuticals (Subject)
Form 425
10/08/2019
3:25 PM
Progenics Pharmaceuticals (Subject)
Form DEFC14A
10/08/2019
10:14 AM
Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form DFAN14A
10/04/2019
4:21 PM
Progenics Pharmaceuticals (Filer)
Form PRER14A
10/04/2019
4:07 PM
Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form 425
10/04/2019
4:05 PM
Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form 425
10/02/2019
4:22 PM
Progenics Pharmaceuticals (Subject)
Form 425
10/02/2019
4:18 PM
Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form 425
10/02/2019
4:17 PM
Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form 425
10/02/2019
3:45 PM
Progenics Pharmaceuticals (Subject)
Form 425
10/02/2019
1:36 PM
Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form DFAN14A
10/02/2019
8:24 AM
Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form 425
10/02/2019
6:42 AM
Progenics Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/02/2019
6:40 AM
Progenics Pharmaceuticals (Subject)
Form 425
10/02/2019
6:27 AM
Lantheus Holdings, Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form 425
09/30/2019
4:23 PM
Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form PRRN14A
09/27/2019
4:23 PM
MacDougall Ann L. (Reporting)
Progenics Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/27/2019
4:21 PM
Mims David W. (Reporting)
Progenics Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/27/2019
4:18 PM
Maeusli Heinz Christoph (Reporting)
Progenics Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/27/2019
4:16 PM
Ende Eric J (Reporting)
Progenics Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/27/2019
4:13 PM
Ber Gerard (Reporting)
Progenics Pharmaceuticals (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
09/25/2019
9:21 AM
Progenics Pharmaceuticals (Subject)
Form PREC14A
09/19/2019
4:23 PM
Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form SC 13D/A
09/18/2019
2:30 PM
Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form DFAN14A
09/18/2019
7:34 AM
Altiva Management Inc. (Filed by)
Progenics Pharmaceuticals (Subject)
Form PREC14A
This page was last updated on 4/7/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel